Clotrimazole for Vulvovaginal Candidosis: More Than 45 Years of Clinical Experience
Vulvovaginal candidosis is a common disease, and various treatment strategies have emerged over the last few decades. Clotrimazole belongs to the drugs of choice for the treatment of vulvovaginal candidosis. Although available for almost 50 years, systematic reviews on the usefulness of topical clot...
Main Authors: | Werner Mendling, Maged Atef El Shazly, Lei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/10/274 |
Similar Items
-
Current concept of the diagnostics and treatment of vulvovaginal candidosis
by: YE. T. Malbakhova, et al.
Published: (2017-08-01) -
Candidal vulvovaginitis in girls: clotrimazole as the drug of choice
by: A. K. Dzhangishieva, et al.
Published: (2019-10-01) -
Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
by: Ali Zarei Mahmoudabadi, et al.
Published: (2013-03-01) -
Comparison of the Effects of Glycyrrhiza Glabra Vaginal Cream and Clotrimazole on the Symptoms of Fungal Vulvovaginitis
by: N Dodangeh, et al.
Published: (2019-04-01) -
Chamomile Extract versus Clotrimazole Vaginal Cream in Treatment of Vulvovaginal Candidiasis: A Randomized Double-Blind Control Trial
by: Zahra Shiravani, et al.
Published: (2021-12-01)